Natera Announces Fourth Quarter and Fiscal 2020 Earnings Conference Call

Rhea-AI Summary

Natera, a leader in cell-free DNA testing, will announce its fourth quarter and year-end financial results on February 25, 2021, after market close. A conference call will follow at 1:30 p.m. PT to discuss the results, business activities, and outlook. Investors can join via live dial-in or through a webcast available on their website. Natera aims to revolutionize disease management with its innovative testing solutions, focusing on women's health, oncology, and organ health.

Positive

• Natera to release fourth quarter and year-end results on February 25, 2021, which may indicate strong performance.
• Potential for positive financial outlook discussed in the upcoming conference call.

Negative

• None.

SAN CARLOS, Calif., Feb. 18, 2021 /PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a pioneer and global leader in cell-free DNA testing, today announced that it will release results for its fourth quarter and year ended December 31, 2020, after the market close on February 25, 2021. Natera will host a conference call and webcast at 1:30 p.m. PT (4:30 p.m. ET) to discuss its financial results, business activities, and financial outlook.

Earnings Conference Call Information:

Event:	Natera's Fourth Quarter and Year-End 2020 Financial Results
Date:	Thursday, February 25, 2021
Time:	1:30 p.m. PT (4:30 p.m. ET)
Live Dial-In:	(877) 823-0171, Domestic (617) 500-6932, International
Password:	8877495
Webcast:	https://edge.media-server.com/mmc/p/ksr9bar5

A webcast replay will be available at investor.natera.com.

About Natera

Natera is a pioneer and global leader in cell-free DNA testing from a simple blood draw. The mission of the company is to change the management of disease worldwide with a focus on women's health, oncology, and organ health. Natera operates ISO 13485-certified and CAP-accredited laboratories certified under the Clinical Laboratory Improvement Amendments (CLIA) in San Carlos, California and Austin, Texas. It offers proprietary genetic testing services to inform obstetricians, transplant physicians, oncologists, and cancer researchers, including biopharmaceutical companies, and genetic laboratories through its cloud-based software platform. For more information, visit natera.com. Follow Natera on LinkedIn.

Contacts

Investor Relations: Mike Brophy, CFO, Natera, Inc., 510-826-2350
Media: Paul Greenland, VP of Corporate Marketing, Natera, Inc., pr@natera.com 

View original content to download multimedia:http://www.prnewswire.com/news-releases/natera-announces-fourth-quarter-and-fiscal-2020-earnings-conference-call-301230669.html

SOURCE Natera, Inc.

FAQ

When will Natera announce its fourth quarter and year-end 2020 financial results?

Natera will release its fourth quarter and year-end 2020 financial results on February 25, 2021.

What time is Natera's earnings conference call scheduled?

The earnings conference call is scheduled for 1:30 p.m. PT on February 25, 2021.

How can I access Natera's earnings conference call?

You can access the conference call via live dial-in or through a webcast on Natera's investor relations website.

What is the focus of Natera's business?

Natera focuses on cell-free DNA testing, particularly in women's health, oncology, and organ health.